• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON MEDICAL (SINGAPORE) BD NEOFLON¿ PRO IV CATHETER; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON MEDICAL (SINGAPORE) BD NEOFLON¿ PRO IV CATHETER; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 391380
Device Problem Material Puncture/Hole (1504)
Patient Problems Erythema (1840); Pain (1994)
Event Date 03/17/2022
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported while using bd neoflon¿ pro iv catheter the needle has gone through the catheter.There was no report of patient impact.The following information was provided by the initial reporter: tip of the needle is blunt and hard to insert, cannula is to soft and to flexible.
 
Manufacturer Narrative
The following fields were updated due to additional information: d9: device available for eval yes, d9: returned to manufacturer on: 21-jul-2022.H6: investigation summary: five photos and two representative samples were received by our quality team for evaluation.From the first two photos, one 26g neoflon pro used sample was observed with the needle pierced through the catheter.A blunt needle cannot be seen clearly from the photo.The third and fourth photos, a patient¿s arm was observed with redness around the wrist area.The fifth photo shows a top web of batch 9242213 and a top web of batch 0081014.The top web of batch 0081014 does not belong to the reported complaint.The representative samples returned are of batch 9263838 and 9353151.Both samples do not belong to the reported complaint.The returned samples were subjected to visual inspection and penetration testing.The samples passed the acceptance criteria, and no abnormalities were observed.A review of the internal manufacturing device records and raw material history files for the reported and unreported lot numbers was performed and no recorded quality problems or rejections to this incident were found.From the returned photos, blood was observed in the catheter.This indicates a successful penetration.It would not be possible to penetrate the vein if the product has the needle pierced through the catheter.Therefore, the probable root cause for the reported defect could be due to the user having partially withdrawing the needle from the catheter and upon reinserting the needle into the vein, the needle pierced through the catheter and damaged the catheter.The manufacturing process was reviewed.There is a 100% online automated vision inspection system that can detect and reject product not meeting the lie distance requirement.If the cannula pierced through the catheter in the manufacturing process, the defect part would be rejected by the automated vision inspection system as the product will not have any lie distance.The sterilization records were reviewed, and no abnormalities were observed.Based on the quality team's investigation, the root cause of this incident cannot be determined.
 
Event Description
It was reported while using bd neoflon¿ pro iv catheter the needle has gone through the catheter.There was no report of patient impact.The following information was provided by the initial reporter: tip of the needle is blunt and hard to insert, cannula is to soft and to flexible.
 
Event Description
It was reported while using bd neoflon¿ pro iv catheter the needle has gone through the catheter.There was no report of patient impact.The following information was provided by the initial reporter: tip of the needle is blunt and hard to insert, cannula is to soft and to flexible.
 
Manufacturer Narrative
The following fields were corrected: d9: device available for eval no.D9: returned to manufacturer on: na.H6: investigation summary : five photos were received by our quality team for evaluation.From the first two photos, a 26g neoflon pro used sample was observed with the needle pierced through the catheter.A blunt needle cannot be seen clearly from the returned photos.From photos three and four, a patient¿s arm was observed with redness around the wrist area.The fifth photo shows a top web of batch 9242213 of catalog 391380 and one top web of batch 0081014 of catalog 391379, which does not belong to the reported complaint.A review of the internal manufacturing device records and raw material history files for the reported lot number was performed and no recorded quality problems or rejections to this incident were found.From the returned photos, blood was observed in the catheter.This indicates a successful penetration.It would not be possible to penetrate the vein if the product has the needle pierced through the catheter.Therefore, the probable root cause for the reported defect could be due to the user partially withdrawing the needle from the catheter and upon reinsertion, the needle pierced through the catheter.The manufacturing process was reviewed.There is a 100% online automated vision inspection system that can detect and reject product not meeting the lie distance requirement.If the cannula pierced through the catheter in the manufacturing process, the defective part would be rejected by the automated vision inspection system as the product would not have any lie distance.The endotoxin level for the reported batch 9242213 and batch 0081014 are acceptable.An allergic reaction (redness / hematomas) at the site of insertion may have occurred due to an incorrect aseptic technique or damaged product package that led to a sterility breach.As no sample was returned, further investigation cannot be performed, and a root cause cannot be determined.H3 other text : see h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEOFLON¿ PRO IV CATHETER
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON MEDICAL (SINGAPORE)
30 tuas avenue 2
singapore
Manufacturer (Section G)
BECTON DICKINSON MEDICAL (SINGAPORE)
30 tuas avenue 2
singapore
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key14048397
MDR Text Key288901839
Report Number8041187-2022-00180
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Reporter Country CodeHR
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 09/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2022
Device Catalogue Number391380
Device Lot Number9242213
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/17/2022
Initial Date FDA Received04/07/2022
Supplement Dates Manufacturer Received08/15/2022
09/02/2022
Supplement Dates FDA Received08/24/2022
10/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/04/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-